Global macrolide drugs market expected to generate revenue of around USD 7.66 billion by end of 2024, growing at a CAGR of around 3.2% between 2018 and 2024. Macrolides are a class of antibacterial drugs that contain large macrocyclic lactone ring. One or more deoxy-sugars, usually desosamine and cladinose are attached to the macrocyclic lactone ring.
Macrolide Drugs Market
The report covers forecast and analysis for the macrolide drugs market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the macrolide drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the macrolide drugs market on a global level.
In order to give the users of this report a comprehensive view of the macrolide drugs market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein types, sales channel, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.
The study provides a decisive view of the macrolide drugs market by segmenting the market based on types, sales channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on type, macrolide drugs market has been segmented into 14-membered ring agents, 14-membered ring agents, 15-membered ring agents (Azalides), 16-membered ring agents, and Ketolides. Based on the sales channel, the macrolide drugs market has been segmented into hospital pharmacies, clinics, hospitals, retail pharmacies, and online pharmacies. Based on region, macrolide drugs market is further segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for macrolide drugs market based on individual segment and sales channel in all the regions and countries.
The report also includes detailed profiles of end players such as Abbott Laboratories, Akorn, Inc., Eli Lilly & Co., Fresenius Kabi USA, Gland Pharma Limited, Neo Química, Macrolide Pharmaceuticals, Mylan N.V., Pfizer, Inc., Sanofi, Merck & Co., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and WOCKHARDT.
This report segments the global macrolide drugs market as follows:
Global Macrolide Drugs Market: By Type
Global Macrolide Drugs Market: By Sales Channel
Global Macrolide Drugs market: By Region